Preeclampsia (PE) is a multisystemic disorder of pregnancy that not only causes perinatal
mortality and morbidity but also has a long-term toll on the maternal and fetal cardiovascular …

Preeclampsia is a pregnancy-specific disease that has no known precise cause. Integrative
biology approach based on multi-omics has been applied to identify upstream pathways and …

Platelets may be pivotal mediators of the thrombotic and coagulopathic complications of
preeclampsia (PE), linking inflammation and thrombosis with endothelial and vascular …

Fetal adaptations to harmful intrauterine environments due to pregnancy disorders such as
preeclampsia (PE) can negatively program the offspring's metabolism, resulting in long-term …

Background The adipokine chemerin regulates adipogenesis and the metabolic function of
both adipocytes and liver. Chemerin is elevated in preeclamptic women, and …

Preeclampsia is a life‐threatening pregnancy disorder. Current clinical assays cannot
predict the onset of preeclampsia until the late 2nd trimester, which often leads to poor …

Background Prediction of preeclampsia risk is key to informing effective maternal care.
Current screening for preeclampsia at 11 to 13 weeks of gestation using maternal …

Introduction Preeclampsia (PE) is a serious pregnancy-related complication caused by high
blood pressure in pregnant women. The severe form has more devastating effects …

Background Selective fetal growth restriction (sFGR) is an extreme complication that
significantly increases the risk of perinatal mortality and long-term adverse neurological …

Preeclampsia, a pregnancy-specific syndrome, poses substantial risks to maternal and
neonatal health, particularly in cases with severe features. Our study focuses on evaluating …